| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |